Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers

被引:40
作者
Bin Seow, Dominique Yuan [1 ]
Yeong, Joe Poh Sheng [1 ]
Lim, Johnathan Xiande [1 ]
Chia, Noel [2 ]
Lim, Jeffrey Chun Tatt [1 ]
Ong, Clara Chong Hui [1 ]
Tan, Puay Hoon [1 ]
Iqbal, Jabed [1 ]
机构
[1] Singapore Gen Hosp, Div Pathol, Dept Anat Pathol, 20 Coll Rd,Level 10, Singapore 169856, Singapore
[2] Natl Univ Singapore Hosp, Dept Pathol, 5,Lower Kent Ridge Rd,1 Main Bldg,Level 3, Singapore 119074, Singapore
关键词
Triple-negative breast cancer; Plasma cells; Tertiary lymphoid structures; B cells; Tumour-infiltrating lymphocytes; TUMOR-INFILTRATING LYMPHOCYTES; IMMUNOGLOBULIN-KAPPA CHAIN; B-CELLS; NEOADJUVANT CHEMOTHERAPY; PROGNOSIS; IMMUNOTHERAPY; CARCINOMA; RESPONSES;
D O I
10.1007/s10549-020-05548-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Triple-negative breast cancers (TNBC) are aggressive tumours that exhibit abundant lymphoid infiltrates which modulate tumour behaviour. Recent findings suggest that TNBC with higher densities of plasma cells are associated with a favourable prognosis, and tertiary lymphoid structures (TLS) have prognostic significance. Here, we studied the phenotype and function of plasma cells in TNBCs by assessing their association with IgG Kappa light chain expression, B cells, and TLS. Methods A retrospective analysis of 269 TNBC cases was performed. Tumour-infiltrating CD38+ plasma cells, CD20+ B cells, and TLS were evaluated on conventional haematoxylin-eosin-stained and immunohistochemical-stained sections of TNBC. We then selected TNBC cases demonstrating the highest and lowest densities of plasma cells, and examined their association with TLS, B cells, as well as immunoglobulin expression using Opal-Vectra multiplex immunofluorescence (IF). Results TNBC with high density of plasma cells showed significantly higher numbers of IgG Kappa+ CD38+ cells (p = 0.0089, p < 0.0001), and higher numbers of TLS (p < 0.0001), compared to TNBC with low density of plasma cells. TNBC with high density of plasma cells also showed higher numbers of CD20+ B cells in the tumour core (p < 0.0001), invasive margin (p < 0.0001), as well as stromal (p = 0.015) compartments. Conclusion TNBC with high density of plasma cells are associated with higher numbers of IgG Kappa+ CD38+ cells, CD20+ B cells, and TLS. Further studies to characterize the function of plasma cell infiltrates and how they may interact with other tumour-infiltrating lymphocytes and TLS in TNBC may help improve existing immunotherapy strategies.
引用
收藏
页码:369 / 377
页数:9
相关论文
共 51 条
  • [1] Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
    Alistar, Angela
    Chou, Jeff W.
    Nagalla, Srikanth
    Black, Michael A.
    D'Agostino, Ralph, Jr.
    Miller, Lance D.
    [J]. GENOME MEDICINE, 2014, 6
  • [2] Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer
    Berntsson, Jonna
    Nodin, Bjorn
    Eberhard, Jakob
    Micke, Patrick
    Jirstrom, Karin
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (05) : 1129 - 1139
  • [3] An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
    Bottai, Giulia
    Raschioni, Carlotta
    Losurdo, Agnese
    Di Tommaso, Luca
    Tinterri, Corrado
    Torrisi, Rosalba
    Reis-Filho, Jorge S.
    Roncalli, Massimo
    Sotiriou, Christos
    Santoro, Armando
    Mantovani, Alberto
    Loi, Sherene
    Santarpia, Libero
    [J]. BREAST CANCER RESEARCH, 2016, 18
  • [4] Multiplexed Quantitative Analysis of CD3, CD8, and CD20 Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
    Brown, Jason R.
    Wimberly, Hallie
    Lannin, Donald R.
    Nixon, Christian
    Rimm, David L.
    Bossuyt, Veerle
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (23) : 5995 - 6005
  • [5] Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer
    Buisseret, Laurence
    Desmedt, Christine
    Garaud, Soizic
    Fornili, Marco
    Wang, Xiaoxiao
    Van den Eyden, Gert
    de Wind, Alexandre
    Duquenne, Sebastien
    Boisson, Anais
    Naveaux, Celine
    Rothe, Francoise
    Rorive, Sandrine
    Decaestecker, Christine
    Larsimont, Denis
    Piccart-Gebhart, Martine
    Biganzoli, Elia
    Sotiriou, Christos
    Willard-Gallo, Karen
    [J]. MODERN PATHOLOGY, 2017, 30 (09) : 1204 - 1212
  • [6] Immunoglobulin Kappa C Predicts Overall Survival in Node-Negative Breast Cancer
    Chen, Zonglin
    Gerhold-Ay, Aslihan
    Gebhard, Susanne
    Boehm, Daniel
    Solbach, Christine
    Lebrecht, Antje
    Battista, Marco
    Sicking, Isabel
    Cotarelo, Christina
    Cadenas, Cristina
    Marchan, Rosemarie
    Stewart, Joanna D.
    Gehrmann, Mathias
    Koelbl, Heinz
    Hengstler, Jan G.
    Schmidt, Marcus
    [J]. PLOS ONE, 2012, 7 (09):
  • [7] Triple-negative breast cancer: therapeutic options
    Cleator, Susan
    Heller, Wolfgang
    Coombes, R. Charles
    [J]. LANCET ONCOLOGY, 2007, 8 (03) : 235 - 244
  • [8] Naturally occurring B-cell responses to breast cancer
    Coronella-Wood, JA
    Hersh, EM
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (12) : 715 - 738
  • [9] Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
    DeNardo, David G.
    Brennan, Donal J.
    Rexhepaj, Elton
    Ruffell, Brian
    Shiao, Stephen L.
    Madden, Stephen F.
    Gallagher, William M.
    Wadhwani, Nikhil
    Keil, Scott D.
    Junaid, Sharfaa A.
    Rugo, Hope S.
    Hwang, E. Shelley
    Jirstroem, Karin
    West, Brian L.
    Coussens, Lisa M.
    [J]. CANCER DISCOVERY, 2011, 1 (01) : 54 - 67
  • [10] Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive and Triple-Negative Primary Breast Cancers
    Denkert, Carsten
    von Minckwitz, Gunter
    Brase, Jan C.
    Sinn, Bruno V.
    Gade, Stephan
    Kronenwett, Ralf
    Pfitzner, Berit M.
    Salat, Christoph
    Loi, Sherene
    Schmitt, Wolfgang D.
    Schem, Christian
    Fisch, Karin
    Darb-Esfahani, Silvia
    Mehta, Keyur
    Sotiriou, Christos
    Wienert, Stephan
    Klare, Peter
    Andre, Fabrice
    Klauschen, Frederick
    Blohmer, Jens-Uwe
    Krappmann, Kristin
    Schmidt, Marcus
    Tesch, Hans
    Kuemmel, Sherko
    Sinn, Peter
    Jackisch, Christian
    Dietel, Manfred
    Reimer, Toralf
    Untch, Michael
    Loibl, Sibylle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) : 983 - 991